Helping You Build Wealth With Honest Research
Since 1996. Try Now

MEMBER'S LOGINX

     
Invalid Username / Password
   
     
   
     
 
Invalid Captcha
   
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

AJANTA PHARMA vs FDC - Comparison Results

Rs 100 invested in...

Loading...
DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    AJANTA PHARMA FDC AJANTA PHARMA/
FDC
 
P/E (TTM) x 38.3 23.9 160.4% View Chart
P/BV x 8.3 3.5 238.5% View Chart
Dividend Yield % 0.3 0.0 -  

Financials

 AJANTA PHARMA   FDC
EQUITY SHARE DATA
    AJANTA PHARMA
Mar-23
FDC
Mar-23
AJANTA PHARMA/
FDC
5-Yr Chart
Click to enlarge
High Rs1,426318 448.7%   
Low Rs1,062229 463.5%   
Sales per share (Unadj.) Rs297.2107.5 276.5%  
Earnings per share (Unadj.) Rs46.711.7 399.7%  
Cash flow per share (Unadj.) Rs57.114.0 406.9%  
Dividends per share (Unadj.) Rs7.000-  
Avg Dividend yield %0.60-  
Book value per share (Unadj.) Rs269.1119.5 225.2%  
Shares outstanding (eoy) m125.91165.91 75.9%   
Bonus / Rights / Conversions 00-  
Price / Sales ratio x4.22.5 164.6%   
Avg P/E ratio x26.623.4 113.8%  
P/CF ratio (eoy) x21.819.5 111.8%  
Price / Book Value ratio x4.62.3 202.0%  
Dividend payout %15.00-   
Avg Mkt Cap Rs m156,63845,368 345.3%   
No. of employees `000NANA-   
Total wages/salary Rs m7,8513,909 200.9%   
Avg. sales/employee Rs Th00-  
Avg. wages/employee Rs Th00-  
Avg. net profit/employee Rs Th00-  
INCOME DATA
Net Sales Rs m37,42617,838 209.8%  
Other income Rs m986512 192.5%   
Total revenues Rs m38,41318,350 209.3%   
Gross profit Rs m7,8332,496 313.8%  
Depreciation Rs m1,308389 335.9%   
Interest Rs m5841 142.9%   
Profit before tax Rs m7,4532,578 289.1%   
Minority Interest Rs m00-   
Prior Period Items Rs m00-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m1,573640 245.8%   
Profit after tax Rs m5,8801,938 303.4%  
Gross profit margin %20.914.0 149.6%  
Effective tax rate %21.124.8 85.0%   
Net profit margin %15.710.9 144.6%  
BALANCE SHEET DATA
Current assets Rs m28,25214,431 195.8%   
Current liabilities Rs m11,3937,296 156.2%   
Net working cap to sales %45.040.0 112.6%  
Current ratio x2.52.0 125.4%  
Inventory Days Days66265 24.8%  
Debtors Days Days10251 4.1%  
Net fixed assets Rs m18,70717,347 107.8%   
Share capital Rs m253166 152.3%   
"Free" reserves Rs m33,62419,655 171.1%   
Net worth Rs m33,87719,820 170.9%   
Long term debt Rs m136 222.0%   
Total assets Rs m47,04731,796 148.0%  
Interest coverage x128.664.1 200.7%   
Debt to equity ratio x00 129.9%  
Sales to assets ratio x0.80.6 141.8%   
Return on assets %12.66.2 202.8%  
Return on equity %17.49.8 177.5%  
Return on capital %22.213.2 167.8%  
Exports to sales %59.90-   
Imports to sales %11.58.5 135.6%   
Exports (fob) Rs m22,420NA-   
Imports (cif) Rs m4,2931,509 284.4%   
Fx inflow Rs m22,4203,259 688.0%   
Fx outflow Rs m4,2931,509 284.4%   
Net fx Rs m18,1271,749 1,036.3%   
CASH FLOW
From Operations Rs m7,9181,549 511.1%  
From Investments Rs m-5,596111 -5,025.6%  
From Financial Activity Rs m-1,079-1,800 59.9%  
Net Cashflow Rs m1,243-138 -898.3%  

Share Holding

Indian Promoters % 66.2 69.7 95.0%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 25.8 10.2 253.0%  
FIIs % 9.1 2.4 374.9%  
ADR/GDR % 0.0 0.0 -  
Free float % 33.8 30.3 111.4%  
Shareholders   54,351 55,341 98.2%  
Pledged promoter(s) holding % 12.3 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare AJANTA PHARMA With:   DIVIS LABORATORIES    CIPLA    SUN PHARMA    DR. REDDYS LAB    ZYDUS LIFESCIENCES    


More on AJANTA PHARMA vs FDC

No comparison is complete without understanding how the stock prices have performed over a period of time.

Here's a brief comparison:

AJANTA PHARMA vs FDC Share Price Performance

Period AJANTA PHARMA FDC S&P BSE HEALTHCARE
1-Day 2.51% 1.06% 1.18%
1-Month 7.60% -4.50% -0.75%
1-Year 92.91% 69.82% 61.82%
3-Year CAGR 21.63% 14.77% 18.16%
5-Year CAGR 26.85% 20.71% 19.79%

* Compound Annual Growth Rate

Here are more details on the AJANTA PHARMA share price and the FDC share price.

Moving on to shareholding structures...

The promoters of AJANTA PHARMA hold a 66.2% stake in the company. In case of FDC the stake stands at 69.7%.

To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of AJANTA PHARMA and the shareholding pattern of FDC.

Finally, a word on dividends...

In the most recent financial year, AJANTA PHARMA paid a dividend of Rs 7.0 per share. This amounted to a Dividend Payout ratio of 15.0%.

FDC paid Rs 0.0, and its dividend payout ratio stood at 0.0%.

You may visit here to review the dividend history of AJANTA PHARMA, and the dividend history of FDC.

For a sector overview, read our pharmaceuticals sector report.



Today's Market

Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising Sensex Today Rallies 639 Points | Suzlon Energy Surges 5%, Grasim Industries 4% | 3 Reasons Why Indian Share Market is Rising(Closing)

After opening the day on positive note, Indian share markets gained the momentum as the session progressed and ended on firm footing.